Press releases

All years

Press releases
20th July 2022

AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma

Press releases
8th June 2022

iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials

Press releases
25th May 2022

iSTAR Medical to Host Symposium on Supraciliary MIGS at EGS Congress

Press releases
10th May 2022

iSTAR Medical Expands Commercial Rollout with First MINIject® Surgeries in Switzerland

Press releases
28th March 2022

iSTAR Medical Continues Market Expansion with First MINIject® Surgeries in the UK

First implantations by Mr Chrys Dimitriou

Press releases
11th January 2022

iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject

Press releases
26th November 2021

Belgian med-tech innovator iSTAR Medical secures €20 million European financing from the EIB

Press releases
17th November 2021

iSTAR Medical receives European market approval for glaucoma implant MINIject

Press releases
12th November 2021

iSTAR Medical present final results from STAR-II European trial for MINIject in glaucoma patients at AAO

Press releases
29th July 2021

iSTAR Medical recruits Paul van Hagen as CFO

Press releases
15th July 2021

iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients

Press releases
16th November 2020

iSTAR Medical’s glaucoma device MINIject shows positive one-year results in European trial

scroll to up
Sign up to receive company news alerts